PAH | Pulmoner Arteriyel Hipertansiyon

• Anasayfa - Anasayfa
  
• Arama - Site İçeriklerinde Arama Sonuçları
  
• İletişim - İletişim
  
• İlgili Linkler - Literatür Arama Siteleri
  
• İlgili Linkler - Tıbbi Terimler Sözlüğü
  
• İlgili Linkler - Hasta Derneği Siteleri
  
• İlgili Linkler - Tıp Derneği Siteleri
  
• PAH Bülteni - PAH Bülten Arşivi
  
• PAH Eğitimi - Online Eğitim ve Sempozyumlar
  
• PAH Eğitimi - Literatürler
  
• PAH Eğitimi - PAH Akademileri
  
• PAH Eğitimi - PAH’ta Tanı Videosu
  
• PAH Eğitimi - Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study.
  
• PAH Eğitimi - Bosentan therapy for pulmonary arterial hypertension.
  
• PAH Eğitimi - Survival with first-line bosentan in patients with primary pulmonary hypertension.
  
• PAH Eğitimi - Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial.
  
• PAH Eğitimi - Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension.
  
• PAH Eğitimi - Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study.
  
• PAH Eğitimi - Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension study.
  
• PAH Eğitimi - Outcome of pediatric patients with pulmonary arterial hypertension in the era of new medical therapies.
  
• PAH Eğitimi - Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: a subgroup analysis.
  
• PAH Eğitimi - Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension.
  
• PAH Eğitimi - Systemic sclerosis associated pulmonary hypertension: improved survival in the current era.
  
• PAH Eğitimi - Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions.
  
• PAH Eğitimi - Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.
  
• PAH Eğitimi - Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil.
  
• PAH Eğitimi - Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases.
  
• PAH Eğitimi - Treat-to-target strategies in pulmonary arterial hypertension: the importance of using multiple goals.
  
• PAH Eğitimi - Early intervention in pulmonary arterial hypertension associated with systemic sclerosis: an essential component of disease management.
  
• PAH Eğitimi - Survival in patients with pulmonary arterial hypertension treated with first-line bosentan.
  
• PAH Eğitimi - Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension.
  
• PAH Eğitimi - Treatment options for paediatric pulmonary arterial hypertension.
  
• PAH Genel Bilgiler - Pulmoner Hipertansiyonun Tanımı
  
• PAH Genel Bilgiler - Pulmoner Hipertansiyon Sınıflandırması
  
• PAH Genel Bilgiler - PAH Semptomları Nelerdir?
  
• PAH Genel Bilgiler - PAH Epidemiyolojisi1
  
• PAH Genel Bilgiler - PAH'ın Patofizyolojisi
  
• PAH Genel Bilgiler - PAH Tanısı Nasıl Konur?
  
• PAH Genel Bilgiler - PAH’ın Şiddeti Nasıl Sınıflandırılır
  
• PAH Genel Bilgiler - PAH Nasıl Tedavi Edilir?1
  
• PAH Genel Bilgiler - ESC-ERS 2009 PAH Tedavi Algoritması1
  
• Referanslar - Referanslar
  
• Tracleer - 2010 Ödülleri
  
• Tracleer - 2011 Ödülleri
  
• Tracleer - Kısa Ürün Bilgisi
  
• Uzmana Sor - Uzmana Sor
  
• PAH Bülten Sayı Listesi